Literature DB >> 12426839

Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study.

Marc W Münter1, Jürgen Debus, Holger Hof, Simeon Nill, Peter Häring, Thomas Bortfeld, Michael Wannenmacher.   

Abstract

PURPOSE: Inverse treatment planning and intensity-modulated radiation therapy (IMRT) promise advantages in the treatment of tumors of the head and neck region. Currently published studies use IMRT only in the treatment of the primary tumor. In these studies, the lymph nodes of the neck were treated using conventional techniques. The feasibility of an IMRT technique which allows treatment of the complete target volume, including the primary tumor and lymph nodes, without a beam split is described. PATIENT AND
METHOD: For inverse treatment planning, the KonRad planning system was used. The primary as well as the secondary PTV (bilateral lymph node levels) were treated with one intensity-modulated primary plan. To increase the dose in the primary PTV and suspicious lymph nodes, an intensity-modulated boost plan was performed. The "step and shoot" IMRT technique was used. A plan comparison between the described IMRT approach and an IMRT approach using a split-beam technique was performed focusing on the treatment time. A patient with a carcinoma of the nasopharynx was treated with curative intent by a combined radiochemotherapy.
RESULTS: The median total dose to the primary PTV was 70 Gy, to suspicious lymph nodes > or = 66.0 Gy, and to the secondary PTV 52 Gy. The defined maximum doses to the organs at risk were not exceeded, and the median dose to the protected parotid gland amounted to 21 Gy. Comparison of the treatment time between both IMRT approaches revealed only a slightly shorter treatment time (1-3 min) for the split-beam IMRT technique without considering the remaining conventional treatment parts of the split-beam IMRT technique. The patient achieved a complete response, and 18 months after treatment no signs of recurrent disease are visible.
CONCLUSIONS: IMRT allows the treatment of the target volumes with high doses combined with an excellent sparing of the organs at risk. The IMRT approach presented here makes the treatment of the whole target volume with a single-beam arrangement feasible and does not increase the treatment time compared to a split-beam IMRT technique. Treatment time was comparable to a conventional three-field technique combined with electrons. This IMRT technique can prevent over- or underdosage at field matchlines in the head and neck region and, moreover, is able to spare parotid glands and therefore better avoid xerostomia compared to conventional techniques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426839     DOI: 10.1007/s00066-002-0987-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

2.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  [Nasopharyngeal carcinoma. A model for modern radio-oncology].

Authors:  M W Münter; E M Stoiber; A D Jensen; J Debus
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

4.  IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.

Authors:  G Studer; P U Huguenin; J B Davis; G Kunz; U M Lütolf; C Glanzmann
Journal:  Radiat Oncol       Date:  2006-03-31       Impact factor: 3.481

5.  Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

Authors:  Stephanie E Combs; Steffen Heeger; Renate Haselmann; Lutz Edler; Jürgen Debus; Daniela Schulz-Ertner
Journal:  BMC Cancer       Date:  2006-05-18       Impact factor: 4.430

Review 6.  Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature.

Authors:  Florian Sterzing; Eva M Stoiber; Simeon Nill; Harald Bauer; Peter Huber; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2009-09-23       Impact factor: 3.481

7.  Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.

Authors:  Judit Boda-Heggemann; Frederick Marc Köhler; Hansjörg Wertz; Michael Ehmann; Brigitte Hermann; Nadja Riesenacker; Beate Küpper; Frank Lohr; Frederik Wenz
Journal:  Radiat Oncol       Date:  2008-11-05       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.